TrialClinical rheumatology2008

An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status.

Arie E van der Bijl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.